Urinary excretion of transforming growth factor-alpha in patients with transitional cell carcinoma

Nan Haw Chow, Hsiao Sheng Liu, Chih Jen Chang, Yun Chan Chi, Tzong Shin Tzai, Eric I.C. Li, Johnny Shinn Nan Lin

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


This study was performed to examine the involvement of transforming growth factor-alpha (TGF-α) in urothelial tumorigenesis. TGF-α urine levels were measured in patients with urothelial carcinoma (n = 68), patients who were tumor-free (n = 58), patients with non-neoplastic inflammatory disease (n = 20), and normal controls (n = 39). Both inflammatory and neoplastic urologic diseases had elevated TGF-α urine levels (169.5 ng/gm and 116.7 ng/gm, respectively) as compared to normal controls (39.1 ng/gm)(p = 0.0001). For patients with active cancer, TGF-α levels were positively associated with histologic grading (P = 0.009), nodular shape, and expression of epidermal growth factor receptor in primary tumour (P = 0.03, respectively). But, there was no important relationship with staging classification, number and size of tumor (P > 0.1, respectively). TGF-α urine levels did not correlate with the serum content (n = 26; P > 0.5), or the immunohistochemical expression of TGF-α (n = 60) in corresponding tumor (P > 0.1). Significant factors in predicting patient survival were clinical staging nodular shape and size of tumor (P < 0.05, respectively). Our data implies that interaction of urinary TGF-α/urothelial epidermal growth factor receptor may play a positive role in the carcinogenesis of human urothelium.

Original languageEnglish
Pages (from-to)2053-2057
Number of pages5
JournalAnticancer research
Issue number3 B
Publication statusPublished - 1998 May

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'Urinary excretion of transforming growth factor-alpha in patients with transitional cell carcinoma'. Together they form a unique fingerprint.

Cite this